We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$17B
AUM Growth
+$1.75B
Cap. Flow
+$808M
Cap. Flow %
4.76%
Top 10 Hldgs %
16.45%
Holding
2,292
New
159
Increased
1,096
Reduced
891
Closed
119
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBD icon
1426
Warner Bros
WBD
$66.2B
$1.13M 0.01%
36,755
-14,875
-29% -$516K
KNL
1427
DELISTED
Knoll, Inc.
KNL
$1.13M 0.01%
+43,294
New +$1.03M
DT icon
1428
Dynatrace
DT
$14.1B
$1.12M 0.01%
19,205
+5,361
+39% +$280K
VVV icon
1429
Valvoline
VVV
$4.55B
$1.12M 0.01%
34,460
+16,781
+95% +$522K
FHI icon
1430
Federated Hermes
FHI
$4.72B
$1.12M 0.01%
32,914
+25,846
+366% +$823K
TPVG icon
1431
TriplePoint Venture Growth BDC
TPVG
$212M
$1.12M 0.01%
73,496
-34,321
-32% -$529K
CHRS icon
1432
Coherus Oncology
CHRS
$195M
$1.11M 0.01%
80,553
+32,670
+68% +$463K
MPLX icon
1433
MPLX
MPLX
$61.3B
$1.11M 0.01%
37,568
-11,655
-24% -$330K
EAD
1434
Allspring Income Opportunities Fund
EAD
$378M
$1.11M 0.01%
126,331
-12,766
-9% -$110K
EOT
1435
Eaton Vance National Municipal Opportunities Trust
EOT
$272M
$1.11M 0.01%
49,249
-875
-2% -$19.7K
INSI
1436
DELISTED
Insight Select Income Fund
INSI
$1.11M 0.01%
51,153
+7,391
+17% +$152K
SAIL
1437
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$1.1M 0.01%
21,623
-291
-1% -$14K
HELE icon
1438
Helen of Troy
HELE
$671M
$1.1M 0.01%
4,834
+62
+1% +$13.6K
HQY icon
1439
HealthEquity
HQY
$8.65B
$1.1M 0.01%
13,682
-3,966
-22% -$302K
CHCO icon
1440
City Holding Co
CHCO
$2.04B
$1.1M 0.01%
14,582
-90
-0.6% -$7.12K
DEI icon
1441
Douglas Emmett
DEI
$1.93B
$1.1M 0.01%
32,600
-1,369
-4% -$46.4K
CVSA
1442
Covista Inc
CVSA
$4.23B
$1.09M 0.01%
30,697
-6,275
-17% -$235K
EMO
1443
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.01B
$1.09M 0.01%
47,413
-11,258
-19% -$243K
IBTX
1444
DELISTED
Independent Bank Group, Inc.
IBTX
$1.09M 0.01%
14,759
+3,005
+26% +$228K
AMN icon
1445
AMN Healthcare
AMN
$1.19B
$1.09M 0.01%
11,250
+790
+8% +$68.6K
TLK icon
1446
Telkom Indonesia
TLK
$14.8B
$1.09M 0.01%
50,118
+4,124
+9% +$95.3K
KB icon
1447
KB Financial Group
KB
$42.6B
$1.08M 0.01%
21,996
+183
+0.8% +$9.13K
CHS
1448
DELISTED
Chicos FAS, Inc.
CHS
$1.08M 0.01%
164,780
+66,244
+67% +$285K
RVNC
1449
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.08M 0.01%
36,431
+1,667
+5% +$48.1K
TPR icon
1450
Tapestry
TPR
$32.7B
$1.07M 0.01%
24,702
-13,532
-35% -$604K

Similar funds

Guggenheim Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Guggenheim Capital held 2,292 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Guggenheim Capital deployed $808M of net new capital in Q2 2021, opening 159 new positions and adding to 1,096 existing holdings. Its largest new stake was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was RXR Acquisition Corp. Units, an estimated $32.6M trimmed.

  • Guggenheim Capital's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.
  • Guggenheim Capital added most to Apple in Q2 2021, an estimated $49.1M increase.
  • Guggenheim Capital's biggest Q2 2021 reduction was RXR Acquisition Corp. Units, cutting an estimated $32.6M.
  • Guggenheim Capital fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q2 2021, selling an estimated $153M.
  • Guggenheim Capital's ten largest holdings make up 16% of its $17B portfolio in Q2 2021.
  • Guggenheim Capital opened 159 new positions and closed 119 in Q2 2021.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Guggenheim Capital's 13F filing for Q2 2021, filed 13 Aug 2021.